SOPHiA Genetics Completes $110M Series F Financing

Proceeds from the financing will allow SOPHiA to embark upon the next stage of its planned global expansion, aimed at satisfying growing clinical and biopharma demand for secure data pooling and knowledge sharing for healthcare professionals.

OneOncology Forms Cancer Clinical Trial SMO Subsidiary

The OneOncology Research Network (OneR), a subsidiary of OneOncology, will provide operational, regulatory, and research support services with the aim of more efficiently executing multi-center clinical trials.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
elderly man with head breaking apart

Feasibility Study Finds Informative Digital Biomarkers of Dementia

Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.
Binary Code Robot Face

The Age of Patient Big Data

When the pandemic heated up early last year, the UK Biobank set out to urgently gather data on COVID-19 diagnostic tests, deaths, and hospitals...

New Prostate Cancer Risk Factors Uncovered by Broad, Diverse Data Study

The researchers showed that men of African ancestry inherit about twice the prostate cancer risk on average compared to men of European ancestry. In contrast, men of Asian ancestry inherit about three-quarters the risk of their white counterparts.
Doctor's Appointment

NorthShore Taps Sema4 in Launch of System-Wide Genomics Program

Already a leader among U.S. health systems in using genomics to guide care, the strategic alliance between NorthShore and Sema4 will significantly expand NorthShore’s existing clinical genomics offerings to more than 1,000 physicians and approximately 300,000 NorthShore patients.

Clinical-Genomic Company Sema4 to Merge with CM Life Sciences

Upon closing of the transaction, expected in the second quarter, CM Life Sciences will be renamed and its stock listed on Nasdaq global exchange. The deal values Sema4 at $2 billion.
Biotechnology, conceptual illustration

Mayo Clinic, Google Partner on AI-Based Diagnostics, Cloud Computing

Mayo Clinic and Google said they will jointly develop artificial intelligence (AI)-based diagnostics and carry out medical research using Google Cloud to store and...
Portrait of business people in crowd

Seven Bridges Launches Genomic, Phenotypic Data Platform Targeted to Drug Developers

According to Seven Bridges, ARIA addresses what the company says is a lack of tools available in the market that allow easy interoperability of disparate data at this scale.

Featured

Scroll Up